Medtronic Receives FDA Clearance for Pulse Oximetry System
The new technology is designed to improve oxygen saturation monitoring reliability across diverse skin tones and patient populations.
The new technology is designed to improve oxygen saturation monitoring reliability across diverse skin tones and patient populations.
The expanded partnership brings integrated patient monitoring technologies into outpatient settings as more procedures shift away from hospitals.
Medtronic advises customers to return affected adult flexible tubes due to potential airway blockage and respiratory emergencies.
The new technology is designed to improve oxygen saturation monitoring reliability across diverse skin tones and patient populations.
Medtronic is poised to acquire EOFlow, the manufacturer of the EOPatch device—a tubeless, wearable, and fully disposable insulin delivery device.
Read MoreMedtronic and DaVita launched a new company committed to reshaping kidney health and driving patient-centered technology solutions.
Read MoreNVIDIA is collaborating with Medtronic to accelerate the development of AI in healthcare and bring new AI-based solutions into patient care.
Read MoreMedtronic announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo...
Read MoreMedtronic published an urgent communication alerting important information regarding the controller driveline cover for its HVAD System.
Read MoreMedtronic intends to pursue a separation of the company’s combined patient monitoring and respiratory Interventions businesses.
Read More
Medtronic received U.S. FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system.